Supplemental material
Journal of Drug Assessment
Volume 8, 2019 - Issue 1
Open access
1,955
Views
17
CrossRef citations to date
0
Altmetric
Psychiatry
Economic burden of relapse/recurrence in patients with major depressive disorder
Genevieve GauthierAnalysis Group, Inc, Montreal, Canada;
, Lisa MuchaTakeda Development Center Americas, Inc, Deerfield, IL, USA
, Sherry ShiAnalysis Group, Inc, Montreal, Canada;
& Annie GuerinAnalysis Group, Inc, Montreal, Canada; Correspondence[email protected]
Pages 97-103
|
Received 07 Jan 2019, Accepted 19 Apr 2019, Published online: 24 May 2019
Related Research Data
Why Collaborative Care for Depressed Patients is so Difficult: A Belgian Qualitative Study
Source:
Ubiquity Press, Ltd.
Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient
Source:
Oxford University Press (OUP)
A Tipping Point for Measurement-Based Care
Source:
American Psychiatric Association Publishing
Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis
Source:
Springer Nature
Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010
Source:
Public Library of Science (PLoS)
Recurrence of major depressive disorder across different treatment settings: Results from the NESDA study
Source:
Elsevier BV
A Tipping Point for Measurement-Based Care
Source:
American Psychiatric Association Publishing
Improving outcomes for patients with depression by enhancing antidepressant therapy with non-pharmacological interventions: A systematic review of reviews
Source:
Elsevier BV
Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials
Source:
Oxford University Press (OUP)
Strategies to Improve the Management of Depression in Primary Care
Source:
Elsevier BV
Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data
Source:
Dove Medical Press Ltd.
Cognitive and neurological impairment in mood disorders
Source:
Elsevier BV
Economic burden of relapse/recurrence in patients with major depressive disorder
Source:
Taylor & Francis
Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder
Source:
Springer Science and Business Media LLC
The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
Source:
Physicians Postgraduate Press, Inc
Risk for recurrence in depression
Source:
Elsevier BV
Economic burden of relapse/recurrence in patients with major depressive disorder
Source:
Taylor & Francis
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.